Aegis Capital Starts Greenwich LifeSciences (GLSI) at Buy
Tweet
Share
E-mailGet Alerts GLSI Hot Sheet
Price: $12.62 --0%
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Rating Summary:
2 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Join SI Premium – FREE
Aegis Capital analyst Nathan Weinstein initiates coverage on Greenwich LifeSciences (NASDAQ: GLSI) with a Buy rating and a price target of $75.00.
For an analyst ratings summary and ratings history on Greenwich LifeSciences click here. For more ratings news on Greenwich LifeSciences click here.
Shares of Greenwich LifeSciences closed at $36.16 yesterday.
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- B.Riley Resumes Taboola (TBLA) at Buy
- Craig-Hallum Assumes Guardant Health (GH) at Buy, 'We think that GH is undervalued'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
